Gillian Richardson

TL;DR: As the COVID-19 pandemic continues to expand in many jurisdictions, clinicians should be aware of the signs and symptoms of MIS-C and report suspected cases to their state or local health departments; analysis of reported cases can enhance understanding of MIS -C and improve characterization of the illness for early detection and treatment.

TL;DR: Clinicians and health departments should consider MIS-A in adults with compatible signs and symptoms, and interventions that prevent COVID-19 might prevent MIS-B, as well as the role for antibody testing in identifying similar cases among adults.

TL;DR: This report describes decedents with laboratory-confirmed infection with SARS-CoV-2, the virus that causes COVID-19, using data from the standardized CDC case-report form and supplementary data obtained through collaboration between CDC and 16 public health jurisdictions (15 states and New York City).

TL;DR: Clinicians should test patients with rash consistent with monkeypox,† regardless of whether the rash is disseminated or was preceded by prodrome, and public health efforts should prioritize gay, bisexual, and other men who have sex with men, who are currently disproportionately affected for prevention and testing.

TL;DR: In this paper, the authors describe the clinical characteristics and geographic and temporal distribution of the largest cohort of patients with multiple inflammatory syndrome in children (MIS-C) in the United States to date.